Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome

Authors: Hanqing He, Rui Yan, Xuewen Tang, Yang Zhou, Xuan Deng, Shuyun Xie

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

In order to control the spread of rubella and reduce the risk for congenital rubella syndrome, an additional rubella vaccination program was set up for all secondary school students since 2008 in Zhejiang, China.

Methods

We conducted a descriptive analysis of rubella incidence among different age groups from 2005 to 2015 and a serosurvey of female subjects aged 15–39 years to understand the possible effects of this immunization program.

Results

The average annual rubella incidence rate had decreased from 15.86 per 100,000 population (2005–2007) to 0.75 per 100,000 population (2013–2015) in Zhejiang. The decrease in the rate of rubella incidence in girls aged 15–19 years was more accelerated (from 138.30 to 0.34 per 100,000) than in the total population during 2008–2015 (from 32.20 to 0.46 per 100,000). Of 1225 female subjects in the serosurvey, 256 (20.9%) were not immune to rubella. The proportion of subjects immune to rubella was significantly different among different age groups (Wald χ2 = 22.19, p = 0.000), and subjects aged 15–19 years old had the highest immunity (88.0%). Rubella antibody levels were significantly lower in women aged 25–30 years with 26.7% of them not immune, followed by the group aged 20–24 years (25.0%) and 30–35 years (24.5%).

Conclusions

Rubella vaccine included in the Expanded Program on Immunization together with vaccination activities for secondary school students can help in rubella control, particularly in targeted age groups in the program. Seroprevalence of antibodies to the rubella virus amongst the female population within childbearing age in Zhejiang, China, is still too low to provide immunity. In addition to vaccination programs in the secondary schools, rubella vaccination should also be encouraged in women of childbearing age, which can be done effectively combined with pre-marital examination in China.
Literature
1.
go back to reference Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4.CrossRefPubMed Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4.CrossRefPubMed
2.
go back to reference Castillo-Solórzano C, Reef SE, Morice A, Andrus JK, Ruiz Matus C, Tambini G, et al. Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas. J Infect Dis. 2011;204:S683–9.CrossRefPubMed Castillo-Solórzano C, Reef SE, Morice A, Andrus JK, Ruiz Matus C, Tambini G, et al. Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas. J Infect Dis. 2011;204:S683–9.CrossRefPubMed
3.
go back to reference Rubella vaccines. WHO position paper. Wkly Epidemiol Rec. 2011;86:301–16. Rubella vaccines. WHO position paper. Wkly Epidemiol Rec. 2011;86:301–16.
4.
go back to reference Centers for Disease Control and Prevention (CDC). Rubella and congenital rubella syndrome control and elimination-global progress, 2000–2012. MMWR Morb Mortal Wkly Rep. 2013;62:983–6. Centers for Disease Control and Prevention (CDC). Rubella and congenital rubella syndrome control and elimination-global progress, 2000–2012. MMWR Morb Mortal Wkly Rep. 2013;62:983–6.
5.
go back to reference Spika JS, Hanon FX, Wassilak S, Pebody R, Emiroglu N. Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro Surveill. 2004;9:4–5.PubMed Spika JS, Hanon FX, Wassilak S, Pebody R, Emiroglu N. Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro Surveill. 2004;9:4–5.PubMed
6.
go back to reference Gao L, Hethcote H. Simulations of rubella vaccination strategies in China. Math Biosci. 2006;202:371–85.CrossRefPubMed Gao L, Hethcote H. Simulations of rubella vaccination strategies in China. Math Biosci. 2006;202:371–85.CrossRefPubMed
7.
go back to reference Wang C, Zhu Z, Xu Q, Xu A, Fang X, Song L, et al. Rubella Epidemics and Genotypic Distribution of the Rubella Virus in Shandong Province, China, in 1999–2010. PLoS One. 2012;7:e42013.CrossRefPubMedPubMedCentral Wang C, Zhu Z, Xu Q, Xu A, Fang X, Song L, et al. Rubella Epidemics and Genotypic Distribution of the Rubella Virus in Shandong Province, China, in 1999–2010. PLoS One. 2012;7:e42013.CrossRefPubMedPubMedCentral
8.
go back to reference Yin ZY, Zhong JY, Gong XY, Lai SM. Epidemiology of rubella in Quzhou, Zhejiang, 2004 to 2012. Dis Surv. 2013;28:672–5. Yin ZY, Zhong JY, Gong XY, Lai SM. Epidemiology of rubella in Quzhou, Zhejiang, 2004 to 2012. Dis Surv. 2013;28:672–5.
9.
go back to reference Liu DL, Sun MP. Study Progress on Congenital Rubella Syndrome. Chin J Vaccines Immunization. 2012;18:76–81. Liu DL, Sun MP. Study Progress on Congenital Rubella Syndrome. Chin J Vaccines Immunization. 2012;18:76–81.
10.
go back to reference Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele J-M, et al. Global control and regional elimination of measles, 2000–2012. MMWR Morb Mortal Wkly Rep. 2014;63:103–7.PubMed Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele J-M, et al. Global control and regional elimination of measles, 2000–2012. MMWR Morb Mortal Wkly Rep. 2014;63:103–7.PubMed
11.
go back to reference He H, Chen EF, Li Q, Wang Z, Yan R, Fu J, et al. Waning immunity to measles in young adults and booster effects of revaccination in secondary school students. Vaccine. 2013;31:533–7.CrossRefPubMed He H, Chen EF, Li Q, Wang Z, Yan R, Fu J, et al. Waning immunity to measles in young adults and booster effects of revaccination in secondary school students. Vaccine. 2013;31:533–7.CrossRefPubMed
12.
go back to reference He HQ, Chen EF, Li Q, Fu J. Observation on the Serological and Epidemiological Effect of Measles Attenuated Live Vaccine Supplementary Immunization Activities for Middle School Students. Chin J Vaccines Immunization. 2011;17:516–9. He HQ, Chen EF, Li Q, Fu J. Observation on the Serological and Epidemiological Effect of Measles Attenuated Live Vaccine Supplementary Immunization Activities for Middle School Students. Chin J Vaccines Immunization. 2011;17:516–9.
13.
go back to reference Zhu Z, Rivailler P, Abernathy E, Cui A, Zhang Y, Mao N, et al. Evolutionary analysis of rubella viruses in mainland China during 2010–2012: endemic circulation of genotype 1E and introductions of genotype 2B. Sci Rep. 2015;5:7999.CrossRefPubMedPubMedCentral Zhu Z, Rivailler P, Abernathy E, Cui A, Zhang Y, Mao N, et al. Evolutionary analysis of rubella viruses in mainland China during 2010–2012: endemic circulation of genotype 1E and introductions of genotype 2B. Sci Rep. 2015;5:7999.CrossRefPubMedPubMedCentral
14.
go back to reference Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50:353–63.CrossRefPubMedPubMedCentral Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50:353–63.CrossRefPubMedPubMedCentral
15.
go back to reference Cameron NA. When, and how, should we introduce a combination measles-mumps-rubella vaccine into the national childhood expanded immunization programme in South Africa? Vaccine. 2012;30:C58–60.CrossRefPubMed Cameron NA. When, and how, should we introduce a combination measles-mumps-rubella vaccine into the national childhood expanded immunization programme in South Africa? Vaccine. 2012;30:C58–60.CrossRefPubMed
16.
go back to reference Centers for Disease Control and Prevention. Nationwide rubella epidemic--Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:457–62. Centers for Disease Control and Prevention. Nationwide rubella epidemic--Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:457–62.
17.
go back to reference Minakami H, Kubo T, Unno N. Causes of a nationwide rubella outbreak in Japan, 2012–2013. J Infect. 2014;68:99–101.CrossRefPubMed Minakami H, Kubo T, Unno N. Causes of a nationwide rubella outbreak in Japan, 2012–2013. J Infect. 2014;68:99–101.CrossRefPubMed
18.
go back to reference Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H. Long-term persistence of antibodies after one or two doses of MMR-vaccine. Vaccine. 2007;25:6672–6.CrossRefPubMed Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H. Long-term persistence of antibodies after one or two doses of MMR-vaccine. Vaccine. 2007;25:6672–6.CrossRefPubMed
19.
go back to reference Mou J, Griffiths SM, Fong HF, Hu Q, Xie X, He Y, et al. Rubella in Female Migrant Factory Workers in Shenzhen, China. Vaccine. 2010;28:7844–51.CrossRefPubMed Mou J, Griffiths SM, Fong HF, Hu Q, Xie X, He Y, et al. Rubella in Female Migrant Factory Workers in Shenzhen, China. Vaccine. 2010;28:7844–51.CrossRefPubMed
20.
go back to reference Centers for Disease Control and Prevention. Progress toward measles elimination--Western Pacific Region, 2009–2012. MMWR Morb Mortal Wkly Rep. 2013;62:443–7. Centers for Disease Control and Prevention. Progress toward measles elimination--Western Pacific Region, 2009–2012. MMWR Morb Mortal Wkly Rep. 2013;62:443–7.
21.
go back to reference Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S, et al. Reducing global disease burden of measles and rubella: report of the WHO Steering Commit-tee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine. 2007;25:1–9.CrossRefPubMed Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S, et al. Reducing global disease burden of measles and rubella: report of the WHO Steering Commit-tee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine. 2007;25:1–9.CrossRefPubMed
22.
go back to reference Poethko-Muller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One. 2012;7:e42867.CrossRefPubMedPubMedCentral Poethko-Muller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One. 2012;7:e42867.CrossRefPubMedPubMedCentral
23.
go back to reference Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, et al. Determining rubella immunity in pregnant Alberta women 2009–2012. Vaccine. 2015;33:635–41.CrossRefPubMed Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, et al. Determining rubella immunity in pregnant Alberta women 2009–2012. Vaccine. 2015;33:635–41.CrossRefPubMed
24.
go back to reference Lim GH, Harris T, Desai S, Crowcroft NS, Mazzulli T, Kozlowski T, et al. Rubella immunity among prenatal women in Ontario, 2006–2010. BMC Infect Dis. 2013;13:362.CrossRefPubMedPubMedCentral Lim GH, Harris T, Desai S, Crowcroft NS, Mazzulli T, Kozlowski T, et al. Rubella immunity among prenatal women in Ontario, 2006–2010. BMC Infect Dis. 2013;13:362.CrossRefPubMedPubMedCentral
25.
go back to reference Byrne L, Brant L, Reynolds C, Ramsay M. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004–2009. Is rubella susceptibility increasing? Vaccine. 2012;30:161–7.CrossRefPubMed Byrne L, Brant L, Reynolds C, Ramsay M. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004–2009. Is rubella susceptibility increasing? Vaccine. 2012;30:161–7.CrossRefPubMed
Metadata
Title
Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome
Authors
Hanqing He
Rui Yan
Xuewen Tang
Yang Zhou
Xuan Deng
Shuyun Xie
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2046-5

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.